| VPS33A Protein | |
|---|---|
| Protein Name | Vacuolar Protein Sorting 33 Homolog A |
| Gene | [VPS33A](/genes/vps33a) |
| UniProt ID | [Q9NXD1](https://www.uniprot.org/uniprotkb/Q9NXD1/entry) |
| Protein Length | 552 amino acids |
| Molecular Weight | 57.7 kDa |
| Subcellular Localization | Synaptic vesicles, lysosomes, endosomes |
| Protein Family | Sec1/Munc18 (SM) family |
| PDB Structures | 5W5V, 6H4J |
VPS33A (Vacuolar Protein Sorting 33 Homolog A) is a member of the Sec1/Munc18 (SM) family of proteins that play critical roles in membrane fusion events throughout the cell[1]. VPS33A is particularly important for synaptic vesicle trafficking, lysosomal function, and autophagy—processes that are central to neuronal health and frequently dysregulated in neurodegenerative diseases. Originally identified in yeast as a component of the vacuolar protein sorting (VPS) pathway, VPS33A has emerged as a significant protein in Parkinson's disease (PD), where genetic variants and functional deficits have been linked to disease pathogenesis[2].
The SM protein family includes key regulators of vesicle trafficking, with VPS33A specifically functioning as a regulator of SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) complex assembly and disassembly. In neurons, VPS33A localizes to synaptic vesicles where it controls neurotransmitter release, and to lysosomes and endosomes where it regulates membrane trafficking pathways critical for cellular homeostasis[3].
VPS33A protein contains several structural features that mediate its diverse cellular functions:
The central Sec1 domain of VPS33A shares homology with other SM proteins:
The N-terminal region contains:
The C-terminal region includes:
VPS33A functions as part of the HOPS (Homotypic fusion and Vacuole Protein Sorting) complex:
VPS33A plays a critical role in synaptic vesicle cycling:
SNARE Complex Regulation:
Synaptic Vesicle Cycle:
Neurotransmitter Release:
VPS33A is essential for lysosomal membrane trafficking:
Lysosomal Fusion:
Autophagy:
VPS33A functions in endosomal sorting:
Endocytic Pathway:
Cargo Sorting:
VPS33A shows specific expression patterns in the nervous system:
VPS33A has emerged as a significant player in PD pathogenesis:
Genetic Evidence:
Functional Studies:
Mechanistic Links:
Pathological Findings:
VPS33A involvement in AD includes:
Autophagy Dysregulation:
Lysosomal Function:
Synaptic Dysfunction:
Huntington's Disease (HD):
Lysosomal Storage Disorders:
Amyotrophic Lateral Sclerosis (ALS):
Small Molecule Approaches:
Gene Therapy:
Autophagy Modulators:
Lysosomal Function:
| Interactor | Function | Reference |
|---|---|---|
| VPS16 | HOPS complex subunit | [10] |
| VPS18 | HOPS complex subunit | [10:1] |
| VPS33B | HOPS complex subunit | [10:2] |
| VPS39 | HOPS complex subunit | [10:3] |
| Syntaxin-1 | SNARE protein | [4:1] |
| SNAP-25 | SNARE protein | [5:1] |
| VAMP2 | Synaptic vesicle SNARE | [11] |
| LAMP1 | Lysosomal membrane protein | [12] |
Protein Analysis:
Cellular Models:
Animal Models:
Clinical Studies:
VPS33A is a critical regulator of synaptic vesicle trafficking, lysosomal function, and autophagy—processes essential for neuronal health and frequently dysregulated in neurodegenerative diseases. Its identification as a PD risk factor, combined with its fundamental roles in cellular trafficking pathways, makes VPS33A a protein of significant therapeutic interest. Understanding how VPS33A dysfunction contributes to neurodegeneration and developing approaches to restore its function may provide novel treatments for PD and related disorders.
Iyer S, et al. VPS33A and Parkinson's disease: genetic and functional studies. Brain. 2019. ↩︎ ↩︎
Hermey K, et al. VPS33A in neuronal function and neurodegenerative disease. Journal of Neurochemistry. 2018. ↩︎
Dowlatshahi DP, et al. VPS33A interacts with syntaxin-1 and regulates synaptic vesicle release. Journal of Neuroscience. 2015. ↩︎ ↩︎
Bal M, et al. VPS33A and synaptic vesicle cycling. Frontiers in Synaptic Neuroscience. 2019. ↩︎ ↩︎
Wang H, et al. VPS33A in autophagy and lysosome function. Cellular and Molecular Life Sciences. 2017. ↩︎
Kelley S, et al. VPS33A in endosomal trafficking. Traffic. 2019. ↩︎
Chen R, et al. VPS33A mutations in patients with early-onset Parkinson's disease. Movement Disorders. 2020. ↩︎
Safronova O, et al. VPS33A regulates alpha-synuclein degradation. Autophagy. 2019. ↩︎
Sato K, et al. The identification of VPS33A as a regulator of lysosomal trafficking. Traffic. 2011. ↩︎ ↩︎ ↩︎ ↩︎
Yu J, et al. VPS33A and neurotransmitter release. Neuroscience Letters. 2018. ↩︎
Gupta A, et al. Lysosomal dysfunction in VPS33A-deficient neurons. Human Molecular Genetics. 2019. ↩︎